Safety and tolerability of adjunctive lacosamide in a pediatric population with focal seizures – An open-label trial-Reference-Cited by-同舟云学术

Safety and tolerability of adjunctive lacosamide in a pediatric population with focal seizures – An open-label trial

Published:2019-10 Issue: Volume:71 Page:166-173
ISSN:1059-1311
Container-title:Seizure
language:en
Short-container-title:Seizure

Author:

Ferreira Jose A.,Le Pichon Jean-Baptiste^ORCID,Abdelmoity Ahmed T.,Dilley Deanne,Dedeken Peter,Daniels Tony,Byrnes William

Funder

UCB Pharma

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,General Medicine

Reference46 articles.

1. AED treatment through different ages: as our brains change, should our drug choices also?;French;Epilepsy Curr,2012

2. Guideline on clinical investigation of medicinal products in the treatment of epileptic disorders, Committee for Medicinal Products for Human Use, London, UK;EMA,2010

3. Antiepileptic drug treatment in children;Hadjiloizou;Expert Rev Neurother,2007

4. Early identification of refractory epilepsy;Kwan;N Engl J Med,2000

5. Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes;Glauser;Epilepsia,2013

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term efficacy, safety, and tolerability, including behavior and executive functioning, during adjunctive lacosamide treatment in pediatric patients with uncontrolled epilepsy;Epilepsy & Behavior;2024-10

2. Anti-seizure Medications: Challenges and Opportunities;CNS & Neurological Disorders - Drug Targets;2024-09

3. Retrospective Multicenter Cohort Study on Safety and Electroencephalographic Response to Lacosamide for Neonatal Seizures;Pediatric Neurology;2024-06

4. Lacosamide extended-release capsules are bioequivalent to lacosamide immediate-release tablets: Pharmacokinetic observations and simulations;Epilepsy Research;2024-05

5. Long‐term safety and efficacy of adjunctive brivaracetam in pediatric patients with epilepsy: An open‐label, follow‐up trial;Epilepsia;2023-09-05